Economic Survey 2025-26 Highlights India’s Shift Toward High-Value Pharma and Innovation

• Economic Survey 2025-26 (tabled Jan 2026) flags Indian pharma's transition from a volume-driven generics powerhouse to a value-driven complex-generics, biosimilars and innovation ecosystem.
• Medical devices sector emerging as a high-tech global manufacturing hub, exporting to 187 countries in FY25.
• Relevant for GS-III (Indian economy, manufacturing, S&T) and government schemes (PLI, Bulk Drug Parks, Medical Device Parks, PMBJP).